Literature DB >> 15609511

Coronavirus reverse genetics by targeted RNA recombination.

P S Masters1, P J M Rottier.   

Abstract

Targeted RNA recombination was the first reverse genetics system devised for coronaviruses at a time when it was not clear whether the construction of full-length infectious cDNA clones would become possible. In its current state targeted RNA recombination offers a versatile and powerful method for the site-directed mutagenesis of the downstream third of the coronavirus genome, which encodes all the viral structural proteins. The development of this system is described, with an emphasis on recent improvements, and multiple applications of this technique to the study of coronavirus molecular biology and pathogenesis are reviewed. Additionally, the relative strengths and limitations of targeted RNA recombination and infectious cDNA systems are contrasted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15609511      PMCID: PMC7122231          DOI: 10.1007/3-540-26765-4_5

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  81 in total

1.  Infectious RNA transcribed in vitro from a cDNA copy of the human coronavirus genome cloned in vaccinia virus.

Authors:  Volker Thiel; Jens Herold; Barbara Schelle; Stuart G Siddell
Journal:  J Gen Virol       Date:  2001-06       Impact factor: 3.891

2.  Coronaviruses maintain viability despite dramatic rearrangements of the strictly conserved genome organization.

Authors:  Cornelis A M de Haan; Haukeline Volders; Cheri A Koetzner; Paul S Masters; Peter J M Rottier
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Genetic recombination with poliovirus type 1. Studies of crosses between a normal horse serum-resistant mutant and several guanidine-resistant mutants of the same strain.

Authors:  N LEDINKO
Journal:  Virology       Date:  1963-05       Impact factor: 3.616

4.  Recombination between nonsegmented RNA genomes of murine coronaviruses.

Authors:  M M Lai; R S Baric; S Makino; J G Keck; J Egbert; J L Leibowitz; S A Stohlman
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

5.  The virulence of mouse hepatitis virus strain A59 is not dependent on efficient spike protein cleavage and cell-to-cell fusion.

Authors:  Susan T Hingley; Isabelle Leparc-Goffart; Su-Hun Seo; Jean C Tsai; Susan R Weiss
Journal:  J Neurovirol       Date:  2002-10       Impact factor: 2.643

6.  Analysis of second-site revertants of a murine coronavirus nucleocapsid protein deletion mutant and construction of nucleocapsid protein mutants by targeted RNA recombination.

Authors:  D Peng; C A Koetzner; P S Masters
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

7.  Strategy for systematic assembly of large RNA and DNA genomes: transmissible gastroenteritis virus model.

Authors:  B Yount; K M Curtis; R S Baric
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

8.  Multiple recombination sites at the 5'-end of murine coronavirus RNA.

Authors:  J G Keck; S A Stohlman; L H Soe; S Makino; M M Lai
Journal:  Virology       Date:  1987-02       Impact factor: 3.616

9.  Sequence comparison of the N genes of five strains of the coronavirus mouse hepatitis virus suggests a three domain structure for the nucleocapsid protein.

Authors:  M M Parker; P S Masters
Journal:  Virology       Date:  1990-11       Impact factor: 3.616

10.  Enhanced green fluorescent protein expression may be used to monitor murine coronavirus spread in vitro and in the mouse central nervous system.

Authors:  Jayasri Das Sarma; Esther Scheen; Su-Hun Seo; Michael Koval; Susan R Weiss
Journal:  J Neurovirol       Date:  2002-10       Impact factor: 2.643

View more
  43 in total

1.  Evolved variants of the membrane protein can partially replace the envelope protein in murine coronavirus assembly.

Authors:  Lili Kuo; Paul S Masters
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Metagenomic analysis of the viromes of three North American bat species: viral diversity among different bat species that share a common habitat.

Authors:  Eric F Donaldson; Aimee N Haskew; J Edward Gates; Jeremy Huynh; Clea J Moore; Matthew B Frieman
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

Review 3.  The molecular biology of coronaviruses.

Authors:  Paul S Masters
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

Review 4.  A contemporary view of coronavirus transcription.

Authors:  Stanley G Sawicki; Dorothea L Sawicki; Stuart G Siddell
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

5.  Neurovirulent Murine Coronavirus JHM.SD Uses Cellular Zinc Metalloproteases for Virus Entry and Cell-Cell Fusion.

Authors:  Judith M Phillips; Tom Gallagher; Susan R Weiss
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

6.  Genetic interactions between an essential 3' cis-acting RNA pseudoknot, replicase gene products, and the extreme 3' end of the mouse coronavirus genome.

Authors:  Roland Züst; Timothy B Miller; Scott J Goebel; Volker Thiel; Paul S Masters
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

7.  Palmitoylations on murine coronavirus spike proteins are essential for virion assembly and infectivity.

Authors:  Edward B Thorp; Joseph A Boscarino; Hillary L Logan; Jeffrey T Goletz; Thomas M Gallagher
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

8.  Expression of hemagglutinin esterase protein from recombinant mouse hepatitis virus enhances neurovirulence.

Authors:  Lubna Kazi; Arjen Lissenberg; Richard Watson; Raoul J de Groot; Susan R Weiss
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 9.  Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission.

Authors:  Rachel L Graham; Ralph S Baric
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

10.  Role of spike protein endodomains in regulating coronavirus entry.

Authors:  Ana Shulla; Tom Gallagher
Journal:  J Biol Chem       Date:  2009-09-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.